Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 enzymes (CYPs) are a superfamily of heme-containing monooxygenases that play essential roles in the biosynthesis of steroid hormones. In human steroidogenesis, key CYP enzymes like CYP11A1, CYP17A1, CYP19A1, CYP21A2, CYP11B1, and CYP11B2 catalyze sequential oxidation reactions converting cholesterol into biologically active steroid hormones. Their activity is essential for sexual differentiation, reproductive function, blood pressure regulation, and stress response. Disorders affecting these enzymes can lead to various diseases, making them important drug targets. Examples include aromatase inhibitors targeting CYP19A1 for estrogen-dependent cancers and abiraterone inhibiting CYP17A1 for prostate cancer.
Inhibition of steroid hormone synthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 Enzymes Involved in Steroidogenesis (Steroidogenic CYPs).